Rulemaking History for OTC Allergy Drug Products

Final Monograph (21 CFR part 341):
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use

OTC Allergy Drug Products found on this page:

Allergy Drug Products: Antihistamines for Cold Symptoms

Advance Notice Of Proposed RulemakingDateFR Citation
Advance Notice of Proposed Rulemaking9/9/197641FR38312disclaimer icon
    Reopening of Administrative Record3/21/198045FR18400disclaimer icon
Notice: Advisory Committee meeting4/29/198348FR19470disclaimer icon
Notice: Republication of 4/29/1983 notice5/6/198348FR20502disclaimer icon
Proposed RuleDateFR Citation
Proposed Rule1/15/198550FR2200disclaimer icon
    Correction2/14/198550FR6199disclaimer icon
    Correction3/6/198550FR9040disclaimer icon
Final RuleDateFR Citation
Final Rule12/9/199257FR58356disclaimer icon

Allergy Drug Products: Chlorocyclizine HCl and Doxylamine Succinate

Proposed RuleDateFR Citation
Proposed Rule: Chlorocyclizine HCl and doxylamine succinate8/24/198752FR31892disclaimer icon
    Correction9/22/198752FR35610disclaimer icon
Final RuleDateFR Citation
Final Rule: doxylamine succinate1/28/199459FR4216

Allergy Drug Products: Bronchodilators for Asthma Symptoms

Proposed RuleDateFR Citation
Tentative Final Monograph10/26/198247FR47520disclaimer icon
Notice: Advisory Committee meeting on metaproterenol4/29/198348FR19470disclaimer icon
Notice: Advisory Committee meeting on metaproterenol5/6/198348FR20502disclaimer icon


Page Last Updated: 02/23/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English